...
首页> 外文期刊>Cell death & disease. >Exosomal miR-130b-3p targets SIK1 to inhibit medulloblastoma tumorigenesis
【24h】

Exosomal miR-130b-3p targets SIK1 to inhibit medulloblastoma tumorigenesis

机译:外泌体miR-130b-3p靶sik1抑制medulloblastoma肿瘤瘤

获取原文
           

摘要

Exosomes are an important carrier for cell communication. miRNAs in exosomes are potential biomarkers and therapeutic targets in different types of cancer. However, the role of exosomal miRNAs in medulloblastoma (MB) patients is largely unknown. In this study, we reported that there was a higher level of miR-130b-3p in exosomes derived from MB patient plasma compared with exosomes from healthy control plasma. Exosomes from MB patient plasma could transfer miR-130b-3p to an MB cell line and played suppressor roles for cell proliferation. miR-130b-3p suppressed MB tumorigenesis by targeting a previously unknown target, serine/threonine-protein kinase 1 (SIK1), through the p53 signaling pathways. In addition, we found an unreported role of SIK1 in promoting MB tumor growth and an SIK1 inhibitor could inhibit MB cell proliferation. This research provides new insight into the molecular mechanism of MB and may provide a new therapeutic strategy for MB treatment.
机译:外泌体是细胞通信的重要载体。外来体中的miRNA是不同类型癌症的潜在生物标志物和治疗靶标。然而,外泌体miRNA在Medulloblastoma(MB)患者中的作用在很大程度上是未知的。在这项研究中,与来自健康对照等离子体的外来体相比,我们报道了衍生自Mb患者血浆的外来体积较高水平的miR-130b-3p。来自MB患者血浆的外泌体可以将miR-130b-3p转移到Mb细胞系中,并为细胞增殖发挥抑制作用作用。通过P53信号传导途径靶向先前未知的靶,丝氨酸/苏氨酸 - 蛋白激酶1(Sik1),MiR-130B-3P抑制MB肿瘤内酯。此外,我们发现Sik1在促进MB肿瘤生长方面的未报告作用,Sik1抑制剂可以抑制Mb细胞增殖。本研究提供了新的洞察MB的分子机制,可为MB治疗提供新的治疗策略。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号